DXCM
DexCom, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website dexcom.com
- Employees(FY) 7500
- ISIN US2521311074
Performance
+0.32%
1W
-9.54%
1M
+5.46%
3M
+37.5%
6M
+2.39%
YTD
+3.66%
1Y
Profile
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Investment Analysis Report: DexCom Inc. (DXCM)
Overview:
DexCom Inc. (DXCM) operates in the Health Technology sector, specifically in the Medical Specialties industry. The company has a market capitalization of $44.82 billion as of the latest available data.
Balance Sheets Analysis:
Key Observations:
-
Goodwill and Intangible Assets: The company...
Technical Analysis of DXCM 2024-05-10
Overview:
In analyzing the technical indicators for DXCM over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for investors lookin...
Recent News & Updates
- 2024-05-11 03:25
- 2024-05-08 08:00
Estimating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)(Simply Wall St.)
- 2024-05-03 22:00
Shhh! 3 Secret IoT Stocks Flying Below Wall Street's Radar(Investorplace)
- 2024-05-03 18:18
- 2024-05-03 10:00
Shhh! 3 Secret IoT Stocks Flying Below Wall Street’s Radar(InvestorPlace)
- 2024-05-01 10:00
- 2024-05-01 00:45
- 2024-04-30 21:00
- 2024-04-30 15:03
Dexcom Stock Continues To Post Very Healthy Profits, Returns(Investor's Business Daily)
- 2024-04-30 12:45
- 2024-04-30 12:35
- 2024-04-30 12:26
- 2024-04-30 10:31
DexCom, Inc. (NASDAQ:DXCM) Q1 2024 Earnings Call Transcript(Insider Monkey)
- 2024-04-30 09:00
- 2024-04-29 21:45
- 2024-04-29 09:45
- 2024-04-27 10:18
DexCom First Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
- 2024-04-26 19:29
- 2024-04-26 15:09
- 2024-04-26 11:37
Analyst Report: DexCom, Inc.(Morningstar Research)
- 2024-04-26 11:08
- 2024-04-26 10:53
- 2024-04-26 10:25
- 2024-04-26 07:09
Q1 2024 Dexcom Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-04-26 04:46
- 2024-04-26 04:15
DexCom: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-04-26 04:12
- 2024-04-26 04:03
Dexcom Reports First Quarter 2024 Financial Results(Businesswire)
- 2024-04-26 01:30
DexCom (DXCM) Q1 2024 Earnings Call Transcript(Motley Fool)
- 2024-04-26 01:03
Decoding DexCom Inc (DXCM): A Strategic SWOT Insight(GuruFocus.com)
Page 1 of 10
previousnext